IP Verse

Moderna Therapeutics, Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Moderna Therapeutics, Inc.

Patent Number:
EP3115064
Title:
Rna-Coded Antibody
Applicant:
CUREVAC AG
Opposition Date:
Aug 24, 2022

Latest patents of Moderna Therapeutics, Inc. opposed by its competitors

Patent:
EP2791160
Grant Date:
Mar 2, 2022
Title:
Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions
Oppositions:
10
Patent:
EP2922554
Grant Date:
Feb 23, 2022
Title:
Terminally Modified Rna
Oppositions:
1
Patent:
EP3019619
Grant Date:
Aug 25, 2021
Title:
Compositions Comprising Synthetic Polynucleotides Encoding Crispr Related Proteins And Synthetic Sgrnas And Methods Of Use
Oppositions:
2
Patent:
EP3492109
Grant Date:
Mar 4, 2020
Title:
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
Oppositions:
2

Competitors of Moderna Therapeutics, Inc.

BIONTECH SE

MAIWALD GMBH

SANOFI

Want to track Moderna Therapeutics, Inc.?

Feel free to send us a message here and we will get back to you